Claudia Lanvers-Kaminsky

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Patient Reported Outcomes

Ejection Fraction

Top Venues

European journal of drug metabolism and pharmacokinetics

Leukemia & lymphoma

Scientific reports

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Marcel Te Vrugt, Janna Sophie Wessolowski, Gerrit Randau, Amelie Alfert, Stephanie Müller, Kenneth Scholten, Claudia Sopalla, Claudia Lanvers-Kaminsky, Marc Hotfilder, Finn Asmus Lamp, Christine Damm-Welk, Jette Luedersen, Gabriele Escherich, Udo Zur Stadt, Lena Behrmann, Wilhelm Woessmann, Ilske Oschlies, Matteo Marzi, Martin Zimmermann, Birgit Burkhardt
Pediatric T-cell lymphoblastic lymphoma but not leukemia harbor TRB::NOTCH1 fusions with unfavorable outcome. Blood (2024)
Gudrun Würthwein, Claudia Lanvers-Kaminsky, Christian Siebel, Joachim Gerß, Anja Möricke, Martin Zimmermann, Jan Stary, Petr Smisek, Martin Schrappe, Carmelo Rizzari, Massimo Zucchetti, Georg Hempel, Sebastian Georg Wicha, Joachim Boos, null null
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data. European journal of drug metabolism and pharmacokinetics 46 (2) (2021)
Christian Siebel, Claudia Lanvers-Kaminsky, Julia Alten, Petr Smisek, Christa Ellen Nath, Carmelo Rizzari, Joachim Boos, Gudrun Würthwein
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach. European journal of drug metabolism and pharmacokinetics (2021)
Christian Siebel, Claudia Lanvers-Kaminsky, Gudrun Würthwein, Georg Hempel, Joachim Boos
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples-implications for doxorubicin drug monitoring. Scientific reports 10 (1) (2020)
Claudia Lanvers-Kaminsky, Andreas Niemann, Maria Eveslage, Joachim Beck, Thomas Köhnke, Sonja Martin, Maike de Wit, Bernd Spriewald, Holger Hauspurg, Dieter Hoelzer, Joachim Boos, Nicola Gökbuget
Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia. Leukemia & lymphoma 61 (1) (2019)
Claudia Lanvers-Kaminsky
Asparaginase pharmacology: challenges still to be faced. Cancer chemotherapy and pharmacology 79 (3) (2017)